@article {yook2020pignol,
	title = {A dual receptor-targeted (DRT) radiation nanomedicine labeled with 177Lu is more potent for killing human breast cancer cells in vitro that co-express HER2 and EGFR than single receptor-targeted (SRT) radiation nanomedicines},
	journal = {Mol. Pharmaceutics},
	volume = {17},
	number = {4},
	year = {2020},
	pages = {1226{\textendash}1236},
	doi = {10.1021/acs.molpharmaceut.9b01259},
	author = {S. Yook and Z. Cai and J. J. Jeong and Y. Lu and M. A. Winnik and J-P. Pignol and R. M. Reilly}
}
@article {cai2082pignol,
	title = {Local radiation treatment of HER2-positive breast cancer using trastuzumab-modified gold nanoparticles labeled with 177Lu},
	journal = {Pharmaceutical Research},
	volume = {34},
	year = {2017},
	pages = {579{\textendash}590},
	doi = {10.1007/s11095-016-2082},
	author = {Z. Cai and S. Yook and Y. Lu and D. Bergstrom and M. A. Winnik and J-P. Pignol and R. M. Reilly}
}
@article {lai2017pignol,
	title = {onte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with 111In, 177Lu or 90Y incorporated into tissue implantable depots},
	journal = {Physics in Medicine and Biology},
	volume = {62},
	year = {2017},
	pages = {8581{\textendash}8599},
	author = {P. Lai and Z. Cai and J-P. Pignol and E. Lechtman and S. Mashouf and Y. Lu and M. A. Winnik and D. A. Jaffray and R. M. Reilly}
}
